Li Ji Ke, Du Wen Juan, Jiang Shu Lin, Tian Hai
Department of Cardiology Surgery, The Second Clinical College of Harbin Medical University, Harbin, China.
Int J Exp Pathol. 2009 Jun;90(3):347-54. doi: 10.1111/j.1365-2613.2009.00642.x.
A disintegrin and metalloprotease-15 (ADAM-15) is a potential novel regulator of inflammatory response and tissue remodelling, which is thought to have the ability to attenuate the cardiac function resulting from myocardial infarction (MI). Therefore, the aim of our study was to investigate the expression of ADAM-15 in rat MI. Wistar rats were subjected to MI by ligation of the left anterior descending coronary artery. Euthanasia was performed at 1, 3, 7 and 14 days following MI. The mRNA and protein expression levels of ADAM-15 were detected respectively by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. The localization of ADAM-15 protein was observed by immunohistochemistry. Compared with sham-MI, the expression of ADAM-15 in MI increased at day 1, reached to maximum at day 3, decreased at day 7 and day 14 gradually. In addition, we also found that the localization of ADAM-15 was mainly at cardiac myocytes in the border area of MI and some macrophages in the border and infarcted areas. This study revealed a significant difference of ADAM-15 expression in rat MI and indicated that ADAM-15 maybe one of the important factors involved in inflammatory response and cardiac remodelling of rat MI.
解整合素金属蛋白酶15(ADAM-15)是炎症反应和组织重塑的一种潜在新型调节因子,被认为具有减轻心肌梗死(MI)所致心功能损害的能力。因此,我们研究的目的是调查ADAM-15在大鼠心肌梗死中的表达情况。通过结扎左冠状动脉前降支使Wistar大鼠发生心肌梗死。在心肌梗死后1天、3天、7天和14天实施安乐死。分别采用逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法检测ADAM-15的mRNA和蛋白表达水平。通过免疫组织化学观察ADAM-15蛋白的定位。与假手术组相比,心肌梗死组ADAM-15的表达在第1天增加,第3天达到峰值,第7天和第14天逐渐下降。此外,我们还发现ADAM-15主要定位于心肌梗死边缘区的心肌细胞以及边缘区和梗死区的一些巨噬细胞。本研究揭示了大鼠心肌梗死中ADAM-15表达存在显著差异,并表明ADAM-15可能是参与大鼠心肌梗死炎症反应和心脏重塑的重要因素之一。